Jul 22 2009
Jewish-American scientists in cooperation Israelis have developed preventative medication that can protect humans against nuclear radiation.
Dramatic discovery by Jewish-American scientists could change world; anti-radiation medication proves effective, safe in tests. Further experiments to be fast tracked, FDA approval possible within 1-2 years.
The ground-breaking medication, developed by Professor Andrei Gudkov – Chief Scientific Officer at Cleveland BioLabs – may have far-reaching implications on the balance of power in the world-, as states capable of providing their citizens with protection against radiation will enjoy a significant strategic advantage vis-à-vis their rivals.
For Israel, the discovery marks a particularly dramatic development that could deeply affect the main issue on the defense establishment’s agenda: Protection against a nuclear attack by Iran or against “dirty bomb” attacks by terror groups.
The medication works by suppressing the “suicide mechanism” of cells hit by radiation, while enabling them to recover from the radiation-induced damages that prompted them to activate the suicide mechanism in the first place.
Gudkov’s discovery may also have immense implications for cancer patients by enabling doctors to better protect patients against radiation. Should the new medication enable cancer patients to be treated with more powerful radiation, our ability to fight the disease could greatly improve. YNET NEWS
RELATED VIDEOS: Islam and the Jews